Denali Therapeutics Inc. ( DNLI ) Stifel 2026 Healthcare Conference 2026 November 11, 2026 9:20 AM EST
Company Participants
Joe Lewcock - Chief Scientific Officer
Conference Call Participants
Paul Matteis - Stifel Nicolaus Canada Inc., Research Division
Presentation
Paul Matteis
Stifel Nicolaus Canada Inc., Research Division
Thanks very much, everybody. Happy to be moderating this chat with Joe Lewcock, Chief Scientific Officer of Denali Therapeutics. I think we'll kick off and maybe hit a couple of questions on the AVLAYAH launch and how that's all going. And then I think we'll use this as an opportunity to maybe do a deeper dive into each pipeline program and preview some of the data readouts next year. But yes, thank you, Joe.
Question-and-Answer Session
Paul Matteis
Stifel Nicolaus Canada Inc., Research Division
So maybe to kick it off, like do you want to just level set for people and review the updates you gave on AVLAYAH in the past quarter?…